Table 3 Mortality risk factors in the AD and non-AD cohorts

 Age at baseline, increase per year

1.07 (1.07–1.07)

1.07 (1.07–1.07)

1.11 (1.11–1.11)

1.12 (1.12–1.12)

  < 80 y

1.00

1.00

1.00

1.00

  ≥ 80 y

2.03 (1.99–2.07)

2.10 (2.06–2.14)

3.07 (2.99–3.15)

3.11 (3.02–3.19)

 Gender, Men (vs women)

1.34 (1.31–1.36)

1.58 (1.55–1.62)

1.16 (1.13–1.19)

1.41 (1.37–1.45)

 Managerial/professional

1.00

1.00

1.00

1.00

 Office worker

1.03 (0.99–1.08)

1.09 (1.05–1.14)

1.19 (1.13–1.26)

1.12 (1.06–1.18)

 Farming/forestry

1.23 (1.20–1.27)

1.05 (1.02–1.08)

1.73 (1.67–1.80)

1.29 (1.24–1.34)

 Sales/industry/cleaning

1.15 (1.12–1.18)

1.08 (1.05–1.11)

1.46 (1.41–1.52)

1.24 (1.19–1.28)

 Unknown/ Did not respond

1.37 (1.32–1.42)

1.16 (1.22–1.21)

1.65 (1.58–1.73)

0.91 (0.87–0.95)

 Any cardiovascular disease

1.36 (1.33–1.38)

1.25 (1.22–1.27)

1.68 (1.64–1.73)

1.52 (1.49–1.56)

 Coronary artery disease

1.45 (1.42–1.48)

1.26 (1.24–1.29)

1.88 (1.83–1.93)

1.57 (1.53–1.61)

 Stroke

1.42 (1.38–1.46)

1.30 (1.27–1.34)

2.12 (2.04–2.2)

1.79 (1.73–1.86)

 Diabetes

1.23 (1.21–1.26)

1.25 (1.22–1.28)

1.62 (1.56–1.67)

1.66 (1.61–1.72)

 Asthma/COPD

1.24 (1.21–1.28)

1.23 (1.19–1.27)

1.49 (1.44–1.54)

1.50 (1.44–1.55)

 History of hip fracture

1.57 (1.51–1.63)

1.35 (1.30–1.41)

2.36 (2.24–2.48)

1.71 (1.62–1.8)

 Cancer treatment within 5 years of start of follow-up

1.40 (1.37–1.44)

1.29 (1.26–1.32)

1.97 (1.92–2.02)

1.90 (1.85–1.95)

 Any mental or behavioral disorder (exc. dementia)

1.09 (1.07–1.11)

1.11 (1.09–1.13)

1.39 (1.36–1.43)

1.41 (1.37–1.44)